After a sluggish few years, the IPO market came back to life in 2013, led by a surge of IPOs by life sciences companies.

In this interview, Latham & Watkins partner Peter Handrinos explains what’s behind this uptick and offers advice to life sciences companies considering an IPO.  

Download the Full Article Here
Back to All Resources